This was the first time to demonstrate the mRNA expression profile and prognostic role of multiple FA metabolic enzymes in ccRCC simultaneously, which concluded FA metabolic enzymes, such as ACLY, HADHA, and ACAT1, were potential prognostic markers of ccRCC. Here, ACLY is linked to nonpapillary renal cell carcinoma.